Basit öğe kaydını göster

dc.contributor.authorTiryaki, Tarık Onur
dc.date.accessioned2021-03-02T18:35:13Z
dc.date.available2021-03-02T18:35:13Z
dc.identifier.citationTiryaki T. O. , "Myelomatous Pleural Effusion: A Rare Involvement in Myeloma", Diğer, ss.55-56, 2020
dc.identifier.otherav_b0f78456-3e1b-41bc-b214-85a20351572a
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/5239
dc.identifier.urihttps://avesis.istanbul.edu.tr/api/publication/b0f78456-3e1b-41bc-b214-85a20351572a/file
dc.description.abstractExtramedullary disease (EMD) incidence is between 7% and 18% in multiple myeloma. Overall survival of patients who develop EMD is significantly shorter than that of patients without EMD. Malignant myelomatous pleural effusions (MPEs) are rarely observed, occurring in less than 1% of cases. The diagnosis of MPE was confirmed by the detection of myeloma cells in the pleural fluid using flow cytometric analyses. We present a case of a 67-year-old male patient with IgGkappa myelom. After a few line treatment regimens, he was admitted to hospital with back pain and blurred consciousness, and pleural effusion was detected. Pleural fluid analysis showed malignant plasma cells. It is a rare presentation of multiple myeloma, but important in diagnosis.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectTIP, GENEL & İÇECEK
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.titleMyelomatous Pleural Effusion: A Rare Involvement in Myeloma
dc.typeDiğer Yayınlar
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Tıp
dc.contributor.firstauthorID1043795


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster